Craft

Pfizer

Stock Price

$28.5

2024-10-29

Market Capitalization

$163.9 B

2024-08-26

Revenue

$62.6 B

FY, 2025

Pfizer Summary

Company Summary

Overview
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The Biopharma segment focuses on the manufacture, marketing, sale, and distribution of biopharmaceutical products. The PC1 segment specializes in the contract development, manufacturing, and supply of specialty active pharmaceutical ingredients. The Pfizer Ignite segment provides strategic guidance and end-to-end R&D services.
Type
Public
Status
Active
Founded
1849
HQ
New York, NY, US | view all locations
Website
https://www.pfizer.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Albert Bourla

    Albert Bourla, Chairman and Chief Executive Officer

  • Dave Denton

    Dave Denton, Chief Financial Officer and Executive Vice President

  • Lidia Fonseca

    Lidia Fonseca, Chief Digital and Technology Officer, Executive Vice President

  • Chris Boshoff

    Chris Boshoff, Chief Scientific Officer and President, Research & Development

Operating MetricsView all

Phase I Trials Products

51
24.4%

FY, 2024

Phase III Trials Products

32
3.2%

FY, 2024

Properties

251
11.6%

FY, 2024

LocationsView all

96 locations detected

  • New York, NY HQ

    United States

    66 Hudson Blvd E

  • Andover, MA

    United States

    1 Burtt Rd

  • Boulder, CO

    United States

    1825, 1865 and 1885 33rd Street

  • Cambridge, MA

    United States

    1 Portland St

  • Chesterfield, MO

    United States

    875 Chesterfield Pkwy W

  • Collegeville, PA

    United States

    500 Arcola Rd

and 90 others

Pfizer Financials

Summary Financials

Revenue (Q1, 2026)
$14.5B
Gross profit (Q1, 2026)
$10.9B
Net income (Q1, 2026)
$2.7B
Cash (Q1, 2026)
$1.7B
Enterprise value
$230.5B

Footer menu